600% revenue growth rate, Sequentify supplies Next Generation Sequencing libraries and software for cancer diagnostics, carrier screening and COVID-19 surveillance REHOVOT, Israel — Sequentify, a Weizmann Institute of Science spinoff, enables fast and focused DNA sequencing. It combines tools from the synthetic biology and AI software fields to enable rapid targeted DNA sequencing. Sequentify exits […]
Collaboration will accelerate plasmid optimization and sourcing services for new and existing viral vector and mRNA-based vaccine and therapeutic customers RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, and Cytovance Biologics, Inc., a biologics contract development and […]
Industry veteran brings decades of experience building and scaling successful commercial strategies for leading life science and diagnostic companies SOUTH SAN FRANCISCO, Calif., and PARIS — DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has added life sciences veteran Chris Barbazette as Chief Commercial Officer to its leadership team. In his […]
Maxwell™ Preclinical MRI Magnets Do Not Require Liquid Helium, Facilitate Siting LONDON — At the ISMRM 2022 conference, Bruker today announced the launch of innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio. Following the success of its BioSpec® Maxwell 3 Tesla model, the new range of Maxwell 7 Tesla […]
UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) today announced that Oxford Genomics at the University of Oxford adopts the Olink technology and becomes the first Olink certified laboratory in the United Kingdom. The partnership will enable novel techniques to unravel mechanisms of disease using the Olink® Explore platform. Oxford Genomics is centered within the […]
GUILFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced the appointment of Patrick Schneider, Ph.D., as President and Chief Operating Officer (COO). Schneider will succeed Michael McKenna, Ph.D., who will remain as Executive Vice President, Product Development and Operations. “We have made […]
BOSTON & MUMBAI, India — TA Associates (“TA”), a leading global growth private equity firm, today announced that the firm has completed a strategic growth investment in Zifo RnD Solutions (“Zifo”), a leading provider of scientific informatics services. Founded in 2008, Zifo helps enable the digital transformation of Drug Discovery, Clinical Development, Manufacturing Quality Control […]
Element Biosciences Expands Leadership Team to Grow Commercial Presence in the DNA Sequencing Market
SAN DIEGO — Element Biosciences Inc., developer of the Element AVITI™ System, a new and disruptive DNA sequencing platform, today announced the appointment of Kelly Choi, MD, as Senior Vice President, Marketing and Product Management. Dr. Choi brings 20 years of commercial leadership experience in product strategy and execution, strategic partnerships, business development, client relations, […]
Life Sciences Finance Veteran To Help Company Scale Globally Amsterdam, the Netherlands – LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity analysis, today announced that Andre Nel has been appointed Chief Financial Officer. He will be based in the Company’s headquarters in Amsterdam. Olivier Heyning, CEO of LUMICKS, […]
New Application Offers an Unparalleled Window into the Complexity of Human Intestinal Immune Response and Expands Novel Drug Development Possibilities Boston, MA – Emulate, Inc., a leading provider of next-generation in vitro models, today announced its new colon immune cell recruitment application, enabling the most human-relevant preclinical assessment of inflammatory bowel disease (IBD) drug candidates. “With this […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
